MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Show more...
FAQ
Mira Pharmaceuticals 今天的股價是多少?▼
MIRA.BOATS 目前價格為 $1.06 USD,過去 24 小時上漲了 +7.93%。在圖表上更密切關注 Mira Pharmaceuticals 股價表現。
Mira Pharmaceuticals 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Mira Pharmaceuticals 的股票以代號 MIRA.BOATS 進行交易。
Mira Pharmaceuticals 的市值是多少?▼
今天 Mira Pharmaceuticals 的市值為 44.39M
Mira Pharmaceuticals 下一次財報日期是什麼時候?▼
Mira Pharmaceuticals 將於 June 03, 2026 公布下一次財報。
Mira Pharmaceuticals 去年的營收是多少?▼
Mira Pharmaceuticals 去年的營收為 0USD。
Mira Pharmaceuticals 去年的淨利是多少?▼
MIRA.BOATS 去年的淨收益為 -15.71MUSD。
Mira Pharmaceuticals 有多少名員工?▼
截至 April 01, 2026,公司共有 2 名員工。
Mira Pharmaceuticals 位於哪個產業?▼
Mira Pharmaceuticals從事於Health Care產業。
Mira Pharmaceuticals 何時完成拆股?▼
Mira Pharmaceuticals 最近沒有進行任何拆股。
Mira Pharmaceuticals 的總部在哪裡?▼
Mira Pharmaceuticals 的總部位於 US 的 Miami。